Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $13,600,000 |
| Sells | 52 | $21,039,880 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Sep 2024 17:46 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Sep 2024 | Sale | 500 | 16.33 | 8,165 | D |
| 21 Aug 2024 16:28 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 19 Aug 2024 | Sale | 500 | 15 | 7,500 | D |
| 18 Jul 2024 20:22 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Jul 2024 | Sale | 1,750 | 27.11 | 47,442 | D |
| 15 Jul 2024 18:13 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 11 Jul 2024 | Sale | 1,996 | 25 | 49,900 | D |
| 12 Jul 2024 17:46 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 10 Jul 2024 | Sale | 12,923 | 22.4869 | 290,598 | D |
| 03 Jul 2024 17:11 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Jul 2024 | Sale | 4,248 | 21.3648 | 90,758 | D |
| 26 Jun 2024 17:07 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 24 Jun 2024 | Sale | 12,930 | 23.1022 | 298,711 | D |
| 20 Jun 2024 16:59 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 17 Jun 2024 | Sale | 1,750 | 23.7106 | 41,494 | D |
| 20 May 2024 20:35 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 May 2024 | Sale | 467 | 25.7543 | 12,027 | D |
| 20 May 2024 20:35 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 May 2024 | Sale | 1,283 | 25.342 | 32,514 | D |
| 18 Apr 2024 20:48 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Apr 2024 | Sale | 1,750 | 25.74 | 45,045 | D |
| 03 Apr 2024 19:18 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Apr 2024 | Sale | 8,153 | 31.78 | 259,102 | D |
| 29 Mar 2024 16:52 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Mar 2024 | Sale | 5,833 | 35.0438 | 204,410 | D |
| 20 Mar 2024 16:40 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 18 Mar 2024 | Sale | 1,750 | 31.27 | 54,722 | D |
| 29 Feb 2024 18:01 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Feb 2024 | Sale | 1,909 | 30 | 57,270 | D |
| 21 Feb 2024 17:41 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Feb 2024 | Sale | 1,750 | 27.67 | 48,422 | D |
| 12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,996 | 27.5 | 54,890 | D |
| 12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 2,916 | 27.5 | 80,190 | D |
| 12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,332 | 27.5 | 36,630 | D |
| 12 Feb 2024 20:22 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 08 Feb 2024 | Sale | 92,001 | 27.1282 | 2,495,822 | D |
| 07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 552 | 30.05 | 16,588 | D |
| 07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 6,000 | 30.05 | 180,300 | D |
| 07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 6,000 | 30.05 | 180,300 | D |
| 07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 12,000 | 30.05 | 360,600 | D |
| 25 Jan 2024 16:59 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 23 Jan 2024 | Sale | 5,696 | 18.4079 | 104,851 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 05 Jan 2024 | Sale | 133 | 20.105 | 2,674 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 04 Jan 2024 | Sale | 40,732 | 20.3084 | 827,202 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 05 Jan 2024 | Sale | 28,104 | 19.5632 | 549,804 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 18 Dec 2023 | Sale | 4,702 | 18.129 | 85,243 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 15 Dec 2023 | Sale | 28,632 | 17.2685 | 494,432 | D |
| 05 Jan 2024 17:44 | FDMT | 4D Molecular Therapeutics Inc | VIKING GLOBAL INVESTORS LP | 10% | 04 Jan 2024 | Sale | 540,000 | 19.53 | 10,546,200 | I |
| 11 May 2023 17:50 | FDMT | 4D Molecular Therapeutics Inc | VIKING GLOBAL INVESTORS LP | 10% | 09 May 2023 | Purchase | 850,000 | 16 | 13,600,000 | I |
| 25 Apr 2023 18:44 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 21 Apr 2023 | Sale | 3,750 | 20 | 75,000 | D |
| 25 Apr 2023 18:43 | FDMT | 4D Molecular Therapeutics Inc | CHACKO JACOB | Director | 21 Apr 2023 | Sale | 5,000 | 20.0539 | 100,270 | D |
| 03 Mar 2023 18:16 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Mar 2023 | Sale | 2,248 | 19.3 | 43,386 | D |
| 23 Feb 2023 19:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 22 Feb 2023 | Sale | 16,449 | 20.224 | 332,665 | D |
| 23 Feb 2023 19:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 21 Feb 2023 | Sale | 907 | 21.4897 | 19,491 | D |
| 23 Feb 2023 19:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 21 Feb 2023 | Sale | 17,090 | 20.9314 | 357,718 | D |
| 23 Jan 2023 19:57 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 20 Jan 2023 | Sale | 8,625 | 20.1886 | 174,127 | D |
| 23 Jan 2023 19:57 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 19 Jan 2023 | Sale | 10,899 | 20.0337 | 218,347 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 16 Dec 2022 | Sale | 26,349 | 23.3863 | 616,206 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 16 Dec 2022 | Sale | 27,595 | 22.6625 | 625,372 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 15 Dec 2022 | Sale | 1,500 | 24.1327 | 36,199 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 15 Dec 2022 | Sale | 31,433 | 23.5602 | 740,568 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 375 | 24.35 | 9,131 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 100 | 24.49 | 2,449 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 200 | 23.44 | 4,688 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 2,450 | 22.9305 | 56,180 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 1,000 | 21.775 | 21,775 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 100 | 24.49 | 2,449 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 400 | 23.25 | 9,300 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 975 | 22.7149 | 22,147 | D |
| 05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 400 | 21.515 | 8,606 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)